Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - October 2013

Point of Care: Innovations of the Future

23 Oct 2013 - 24 Oct 2013 - London, UK

Bookmark and Share

Join SMi's highly successful 10th annual Point of Care: Innovations of the Future conference promising to be a must see event!

SMi’s highly respected and eagerly anticipated 10th Annual Point of Care: Innovations of the Future conference comes to London for what promises to be a highly thought provoking and thrilling event. Join a plethora of highly respected speakers as they discuss topics ranging from the analysis of how the future of Point of Care testing will look and change over the next decade to the different strategies medical trusts are putting in place to increase the use of Point of Care testing within the patient care setting. Identify potential gaps in the market for new technologies and learn how to successfully implement these in a highly competitive market place.

This year’s Point of Care: Innovations of the Future conference will focus on technologies aimed at treating infectious diseases, with a focus on the rapid identification and ‘on the spot’ diagnosis of infectious diseases such as HIV and TB. This year’s event will take a look at what strategies different healthcare trusts are implementing to increase the usage of Point of Care testing and diagnosis at the site of the patient.


Identify key industry trends and market opportunities

Discover new technological applications and the latest advances in device technology

Learn how to overcome potential barriers to commercialisation of a new technology

Gain an insight into the future of POC technologies

Understand the benefits of non-invasive patient testing and how new profiling technologies lead to a better personalised treatment approach


Till Bachmann, Reader in Personalised Medicine in Infectious Diseases, University of Edinburgh

Trevor Lewis, CEO, Medical Device Consultancy

Phil Lefebvre, Senior Manager, Business Development, Abbott Laboratories

Penny Wilson, Innovation Platform Leader, Technology Strategy

Roger Peck, Technical Officer, PATH

Tony Gibson, Scientific Director, North East Pathology Network Coordinator

David Huckle, Chief Executive, Adams Business Associates

Maurice O’Kane, Consultant Chemical Pathologist /Director for Research and Development, Western Health and Social Care Trust

Mohammad Al-Ubaydli, CEO, Patients Know Best

Kavita Oberoi, Founder and Managing Director, Oberoi Consulting

Gillian Hall, POCT Coordinator, Royal Brompton and Harefield NHS Foundation Trust

Per Simonsson, Professor of Clinical Chemistry, University Hospital MAS

Nigel Sansom, Senior Manager, Celaris Biosystems

Jose Manuel Costa, Associate Professor, University of Oviedo

Brian Winn, Partner, NHS Institute for Innovation and Improvement

John Rippeth, Principle Consultant, PA Consulting

Contact: Darryl Moxon, Phone: +44 20 7827 6066, Email:

For Sponsorship opportunities contact Alia Malick on +44 (0)20 7827 6168 or email

Further information
Scientific News
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Key Piece of MRSA Vaccine Puzzle
New research funded by the Health Research Board and the Wellcome Trust has pinpointed immune cells that could be targeted by an MRSA vaccine.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos